quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:07·451d
SECFiling
Virpax Pharmaceuticals Inc. logo

SEC Form EFFECT filed by Virpax Pharmaceuticals Inc.

VRPX· Virpax Pharmaceuticals Inc.
Health Care
Original source

Companies

  • VRPX
    Virpax Pharmaceuticals Inc.
    Health Care

Related

  • SEC276d
    SEC Form 25-NSE filed by Virpax Pharmaceuticals Inc.
  • SEC385d
    Amendment: Virpax Pharmaceuticals Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Leadership Update, Financial Statements and Exhibits
  • SEC385d
    Virpax Pharmaceuticals Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Leadership Update, Financial Statements and Exhibits
  • SEC395d
    Amendment: SEC Form S-1/A filed by Virpax Pharmaceuticals Inc.
  • SEC398d
    Virpax Pharmaceuticals Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
  • PR401d
    Virpax Pharmaceuticals Announces Reverse Stock Split
  • PR401d
    Virpax Receives Positive Probudur™ Results for Dose Range Study Moves Towards Next Steps in IND
  • SEC402d
    SEC Form S-1 filed by Virpax Pharmaceuticals Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022